Partial HELLP Syndrome Complicated by Leukocytosis in Pregnant Woman Undergoing Intensive Care in a Hospital : Case Report
DOI:
https://doi.org/10.55227/ijhet.v4i5.517Keywords:
Partial HELLP Syndrome, Leukocytosis, Eclampsia, Sepsis, Multi-Organ DysfunctionAbstract
HELLP syndrome (Hemolysis, Elevated Liver enzymes, and Low Platelet count) is a severe obstetric condition that may occur during pregnancy or postpartum, often associated with preeclampsia. Partial or incomplete HELLP syndrome presents a diagnostic challenge when only one or two of the three defining criteria are met. This report describes a 30-year-old woman, gravida 2 para 1 at 33–34 weeks of gestation, who developed eclampsia and partial HELLP syndrome complicated by severe leukocytosis. Despite an emergency cesarean section and intensive care management, including magnesium sulfate, corticosteroids, broad-spectrum antibiotics, and ventilatory support, the patient’s condition deteriorated to sepsis, acute respiratory distress syndrome (ARDS), and multi-organ dysfunction. Extreme leukocytosis (>40,000/µL) complicated the diagnostic process, mimicking infectious etiology. This case emphasizes the importance of differentiating inflammatory from infectious leukocytosis in HELLP syndrome and underscores the necessity of a multidisciplinary approach, timely delivery, and intensive monitoring. Even in its partial form, HELLP syndrome remains a life-threatening disorder that requires early recognition and aggressive management to improve maternal outcomes.
Downloads
References
Abdullahi F. M., Fajardo T., Migisha R., Kato K., Tibaijuka L., Ngonzi J., Kayondo M., Byamukama O., Lugobe H. M. “HELLP syndrome and associated factors among pregnant women with preeclampsia/eclampsia at a referral hospital in southwestern Uganda: a cross-sectional study.” BMC Pregnancy & Childbirth. 2024;24:626.
Khan H., Ramus R. M. “HELLP Syndrome Treatment & Management.” Medscape Reference. Updated Aug 08 2024.
Corticosteroids for improving patient-relevant outcomes in HELLP syndrome: a systematic review and meta-analysis.” BMC Pregnancy and Childbirth. 2024;24:487.
Mossayebi M. H. et al. “HELLP syndrome at <23 weeks’ gestation: a systematic review.” American Journal of Obstetrics & Gynecology. 2023.
Yan C. et al. “Rescue of a spontaneous subcapsular hepatic hematoma complicating HELLP syndrome.” Medicine (Baltimore). 2024;103(1):e4644.
Minhas S., Gupta M., Shekhawat V., Dagar S. “Partial HELLP syndrome: case report.” International Journal of Reproduction, Contraception, Obstetrics and Gynecology. 2021;10(12):4570-2.
Christian R., Hetharia F. P., Miandy H. M. “Management of HELLP syndrome before delivery: a comprehensive systematic review.” Journal of Advance Research in Medical & Health Science. 2024;10(3):282-289.
Gu H. et al. “Comparison of Clinical Characteristics and Pregnancy Outcomes in Partial and Complete HELLP Syndromes.” Clinics and Experimental Obstetrics & Gynecology (CEOG). 2025;52(3).
Murali A. R. “Two cases of postpartum HELLP syndrome.” European Journal of Medical. 2024;11(4):2051.
Kahar L. A., Sari W. M., Bennovry R. R., Adnani M. R. S. “Intensive care management of eclampsia with HELLP syndrome: a case report.” Bioscientia Medicina: Journal of Biomedicine & Translational Research. 2023;7(10):3658-62.
Ismerat D. I. et al. “Typical presentation of pre-viable HELLP syndrome: a case report.” Journal of Surgical Case Reports. 2025; rjaf255.
Mazzola A. et al. “Acute liver failure and HELLP syndrome: a clinical case.” Liver International. 2021.
Rimboeck J. et al. “Obesity correlates with chronic inflammation of the innate immune system: comparison to HELLP syndrome leukocytosis.” Biomolecules. 2023;11(10):2851.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Richa Difayana Sari, Hana Iftitah Hidayati, Yuliana Arisanti

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
























